speb/financial-data huggingface dataset:
IKT — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 510356067
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
IKT — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 343901472.84
Net income (USD): -13678735
P/B ratio: 4.011416973845719
Pays dividend: no
Net asset value (USD): 85730672
Net cash (USD): 84629641
Net cash to market cap %: 24.608688151613094
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 23.064374558254542 (Safe Zone)
Piotroski F-score: 2 (Weak)
IKT — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 306213640.2
Net income (USD): -9915523
P/B ratio: 3.8251036189027396
Pays dividend: no
Net asset value (USD): 80053685
Net cash (USD): 78866224
Net cash to market cap %: 25.755294228072078
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 19.68454774200956 (Safe Zone)
Piotroski F-score: 4 (Weak)
IKT — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 254392870.32000002
Net income (USD): -11930280
P/B ratio: 3.489695607433798
Pays dividend: no
Net asset value (USD): 72898298
Net cash (USD): 70625974
Net cash to market cap %: 27.76256029155212
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 21.041892746102974 (Safe Zone)
Piotroski F-score: 4 (Weak)
IKT — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 321916903.79999995
Net income (USD): -12734651
P/B ratio: 1.8618279591378732
Pays dividend: no
Net asset value (USD): 172903679
Net cash (USD): 170463191
Net cash to market cap %: 52.95254427083616
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 23.064997041970045 (Safe Zone)
Piotroski F-score: 4 (Weak)
IKT — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 365886048
Net income (USD): -16380840
P/B ratio: 1.5738838245981088
Pays dividend: no
Net asset value (USD): 167620268
Net cash (USD): 164656786
Net cash to market cap %: 45.002204074204
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 37.95461649015257 (Safe Zone)
Piotroski F-score: 3 (Weak)
ILPT — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Real Estate | Industry: REIT - Industrial
Lynch category:  (confidence: Low)
Market cap (USD): 303994547.76
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
ILPT — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Real Estate | Industry: REIT - Industrial
Lynch category:  (confidence: Low)
Market cap (USD): 233329148.5
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
ILPT — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Real Estate | Industry: REIT - Industrial
Lynch category: Turnaround (confidence: High)
Market cap (USD): 220662709.01
Net income (USD): -21532000
P/B ratio: 0.22587754386521625
Pays dividend: no
Net asset value (USD): 539525000
Net cash (USD): -4278761000
Net cash to market cap %: -1939.0503357801592
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.111336818346343 (Distress Zone)
Piotroski F-score: 3 (Weak)
ILPT — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Real Estate | Industry: REIT - Industrial
Lynch category: Turnaround (confidence: High)
Market cap (USD): 292661417.69
Net income (USD): -21310000
P/B ratio: 0.3087914477549263
Pays dividend: no
Net asset value (USD): 519114000
Net cash (USD): -4232225000
Net cash to market cap %: -1446.1164827961577
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.10534967373133756 (Distress Zone)
Piotroski F-score: 4 (Weak)
ILPT — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Real Estate | Industry: REIT - Industrial
Lynch category: Turnaround (confidence: High)
Market cap (USD): 378659875.28
Net income (USD): -21565000
P/B ratio: 0.41445648159539417
Pays dividend: no
Net asset value (USD): 494120000
Net cash (USD): -4222043000
Net cash to market cap %: -1114.996141822001
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.11171527840390792 (Distress Zone)
Piotroski F-score: 4 (Weak)
ILPT — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Real Estate | Industry: REIT - Industrial
Lynch category: Turnaround (confidence: High)
Market cap (USD): 363326816.95
Net income (USD): -1780000
P/B ratio: 0.4033836168726921
Pays dividend: no
Net asset value (USD): 489697000
Net cash (USD): -4194434000
Net cash to market cap %: -1154.4520812448661
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.11041767505303399 (Distress Zone)
Piotroski F-score: 6 (Neutral)
ILPT — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Real Estate | Industry: REIT - Industrial
Lynch category: Turnaround (confidence: High)
Market cap (USD): 613322304
Net income (USD): -9427000
Revenue growth %: 4.033778651534784
Smoothed growth %: 4.033778651534784
P/B ratio: 0.42548046369149395
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): 479718000
Net cash (USD): -4183573000
Net cash to market cap %: -682.1165597134391
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 0.1460148384976176 (Distress Zone)
Piotroski F-score: 6 (Neutral)
IMC.MC — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Industrials | Industry: Conglomerates
Lynch category: Asset Play (confidence: High)
Market cap (USD): 1439396224.0000002
P/B ratio: 0.4702372505717086
Pays dividend: no
Net asset value (USD): 2175852083.3333335
Net cash (USD): -1585251041.6666667
Net cash to market cap %: -110.13305545997225
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
IMC.MC — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Industrials | Industry: Conglomerates
Lynch category: Asset Play (confidence: High)
Market cap (USD): 1786099091.5764706
P/B ratio: 0.4770587797827037
Pays dividend: no
Net asset value (USD): 2717320000
Net cash (USD): -1493289411.764706
Net cash to market cap %: -83.60619065354761
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 3 (Weak)
IMC.MC — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Industrials | Industry: Conglomerates
Lynch category: Asset Play (confidence: High)
Market cap (USD): 2064174381.1764708
P/E ratio: 5.557275541795666
P/B ratio: 0.4998279422378027
Dividend yield: 0.04
Pays dividend: yes
Net asset value (USD): 2855584705.882353
Net cash (USD): -1388267058.8235295
Net cash to market cap %: -67.2553187116047
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 2 (Weak)
IMCR — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 1741637253.76
Pays dividend: no
Net cash (USD): 433864506.6621622
Net cash to market cap %: 24.91130146220157
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
IMCR — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 2902898308.18
Net income (USD): -63304819.27710844
P/B ratio: 7.1094253983865565
Pays dividend: no
Net asset value (USD): 408316867.4698795
Net cash (USD): 258569879.51807228
Net cash to market cap %: 8.907300637761065
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 6.72026162154403 (Safe Zone)
Piotroski F-score: 2 (Weak)
IMCR — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 3475136015.68
Net income (USD): -69983544.30379747
Revenue growth %: 50.295803432410224
Smoothed growth %: 50.295803432410224
P/B ratio: 7.443159968840944
Pays dividend: no
Net asset value (USD): 466889873.4177215
Net cash (USD): 271478481.0126582
Net cash to market cap %: 7.812024616813061
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 6.344918913508489 (Safe Zone)
Piotroski F-score: 7 (Neutral)
IMCR — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 1500534433
Net income (USD): -63858750
Revenue growth %: 22.810781067081486
Smoothed growth %: 22.810781067081486
P/B ratio: 3.3279021346433204
Pays dividend: no
Net asset value (USD): 450895000
Net cash (USD): 214482500
Net cash to market cap %: 14.293740635540617
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 0.9366378993220761 (Distress Zone)
Piotroski F-score: 5 (Neutral)
IMCR — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 1765544073.54
Net income (USD): -47991891.89189189
Revenue growth %: 39.409072065857
Smoothed growth %: 39.409072065857
P/B ratio: 3.4288437337962847
Pays dividend: no
Net asset value (USD): 514909459.4594595
Net cash (USD): 240428378.3783784
Net cash to market cap %: 13.617806656976173
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 1.129784094970883 (Distress Zone)
Piotroski F-score: 5 (Neutral)
IME.AX — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category:  (confidence: Low)
Market cap (USD): 12838739.47826087
P/B ratio: 1.428113006691215
Pays dividend: no
Net asset value (USD): 3941704.347826087
Net cash (USD): -3267596.273291925
Net cash to market cap %: -25.451067675489213
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
IME.AX — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category:  (confidence: Low)
Market cap (USD): 11134693.288590604
P/B ratio: 1.3711245380439543
Pays dividend: no
Net asset value (USD): 6186018.120805369
Net cash (USD): -3060154.3624161077
Net cash to market cap %: -27.483059327298747
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
IMM.V — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Basic Materials | Industry: Other Precious Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 2665684.5037037036
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
IMM.V — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Basic Materials | Industry: Other Precious Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1258277.6503496505
Net income (USD): -90510.48951048951
Pays dividend: no
Net asset value (USD): -1183204.195804196
Net cash (USD): -1231881.8181818181
Net cash to market cap %: -97.90222514398968
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -464.7142843728094 (Distress Zone)
Piotroski F-score: 1 (Weak)
IMM.V — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Basic Materials | Industry: Other Precious Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1572847.0629370632
Net income (USD): -402525.87412587414
Pays dividend: no
Net asset value (USD): -973451.7482517483
Net cash (USD): -980339.1608391609
Net cash to market cap %: -62.32895644720347
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -2803.8922981847218 (Distress Zone)
Piotroski F-score: 2 (Weak)
IMM.V — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Basic Materials | Industry: Other Precious Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1149211.6131386862
Net income (USD): -40964.233576642335
Pays dividend: no
Net asset value (USD): -1057048.9051094889
Net cash (USD): -1064740.1459854012
Net cash to market cap %: -92.64961594648531
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -2771.636206455416 (Distress Zone)
Piotroski F-score: 3 (Weak)
IMM.V — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Basic Materials | Industry: Other Precious Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1779919.7338129499
Net income (USD): -102222.30215827339
Pays dividend: no
Net asset value (USD): -1144061.8705035972
Net cash (USD): -1147480.5755395684
Net cash to market cap %: -64.46810795683645
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -2685.2394907657017 (Distress Zone)
Piotroski F-score: 1 (Weak)
IMM.V — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Basic Materials | Industry: Other Precious Metals & Mining
Lynch category: Cyclical (confidence: High)
Market cap (USD): 985037.9562043794
Net income (USD): -77434.30656934305
Pays dividend: no
Net asset value (USD): -1238197.810218978
Net cash (USD): -1244981.7518248176
Net cash to market cap %: -126.38921617011314
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -1734.8110672110015 (Distress Zone)
Piotroski F-score: 5 (Neutral)
IMMO.BR — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Real Estate | Industry: Real Estate - Development
Lynch category:  (confidence: Low)
Market cap (USD): 700013182.2954545
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
IMMO.BR — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Real Estate | Industry: Real Estate - Development
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 422815568.5531915
Net income (USD): 11407446.808510639
P/E ratio: 37.064873117597685
P/B ratio: 0.6934547134033571
Pays dividend: no
Net asset value (USD): 590632978.7234043
Net cash (USD): -952419148.9361703
Net cash to market cap %: -225.25640486588495
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.3484723493414903 (Distress Zone)
Piotroski F-score: 2 (Weak)
IMMO.BR — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Real Estate | Industry: Real Estate - Development
Lynch category: Turnaround (confidence: High)
Market cap (USD): 312625290.6
Net income (USD): -41763333.333333336
EPS growth %: -466.10587833006934
Revenue growth %: -30.882781929644892
Smoothed growth %: -30.882781929644892
P/B ratio: 0.5608466866796232
Pays dividend: no
Net asset value (USD): 536783333.3333333
Net cash (USD): -1213153333.3333333
Net cash to market cap %: -388.05348441420466
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.2060313899901418 (Distress Zone)
Piotroski F-score: 3 (Weak)
IMMO.BR — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Real Estate | Industry: Real Estate - Development
Lynch category: Turnaround (confidence: High)
Market cap (USD): 199226176.875
Net income (USD): -97488541.66666667
Revenue growth %: 126.31820013045314
Smoothed growth %: 126.31820013045314
P/B ratio: 0.4779432831792727
Pays dividend: no
Net asset value (USD): 395638541.6666667
Net cash (USD): -1027672916.6666667
Net cash to market cap %: -515.8322730408349
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.0146528267061838 (Distress Zone)
Piotroski F-score: 4 (Weak)
IMMO.BR — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Real Estate | Industry: Real Estate - Development
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 264715745.88235295
Net income (USD): 57560000
Revenue growth %: -0.11401766578856329
Smoothed growth %: -0.11401766578856329
P/E ratio: 5.9201410757022295
P/B ratio: 0.5291474172264162
Pays dividend: no
Net asset value (USD): 508372941.1764706
Net cash (USD): -941054117.6470587
Net cash to market cap %: -355.4960867591493
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.2682882064101477 (Distress Zone)
Piotroski F-score: 9 (Strong)
IMMR — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Technology | Industry: Software - Application
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 167157282.6
Net income (USD): 12484000
P/E ratio: 13.389721451457866
P/B ratio: 1.1830374931880108
Pays dividend: no
Net asset value (USD): 141295000
Net cash (USD): 103696000
Net cash to market cap %: 62.03498787913414
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.5960417010984864 (Safe Zone)
Piotroski F-score: 3 (Weak)
IMMR — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Technology | Industry: Software - Application
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 205884811.44
Net income (USD): 30664000
EPS growth %: 145.6264017942967
Revenue growth %: 9.609849240502722
Smoothed growth %: 145.6264017942967
P/E ratio: 6.714219000782677
P/B ratio: 1.3055473141407734
PEG ratio: 0.046105781081282146
Pays dividend: no
Net asset value (USD): 157700000
Net cash (USD): 117328000
Net cash to market cap %: 56.98720521411184
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.820913540144054 (Safe Zone)
Piotroski F-score: 8 (Strong)
IMMR — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Technology | Industry: Software - Application
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 212835906.35999998
Net income (USD): 33976000
EPS growth %: 10.800939212105401
Revenue growth %: -11.809365331114636
EPS 2-year CAGR %: 64.97162184478289
Smoothed growth %: 64.97162184478289
P/E ratio: 6.264301458676712
P/B ratio: 1.162389850247403
PEG ratio: 0.09641596255119073
Pays dividend: no
Net asset value (USD): 183102000
Net cash (USD): 127733000
Net cash to market cap %: 60.01477954755755
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.963136249780672 (Safe Zone)
Piotroski F-score: 4 (Weak)
IMMR — Peter Lynch category analysis (annual, as of 2025-04-30)
Sector: Technology | Industry: Software - Application
Lynch category: Asset Play (confidence: High)
Market cap (USD): 231041154.96
Net income (USD): 93582000
EPS growth %: 175.4356016011302
Revenue growth %: 4487.0338158554205
EPS 2-year CAGR %: 74.69551611262526
Smoothed growth %: 74.69551611262526
P/E ratio: 2.4688631890748223
P/B ratio: 0.4135371803220004
PEG ratio: 0.03305236134056951
Pays dividend: no
Net asset value (USD): 137382000
Net cash (USD): -382181000
Net cash to market cap %: -165.4168496803813
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.46200130376044 (Grey Zone)
Piotroski F-score: 3 (Weak)
IMNM — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 1467725106.24
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
IMNM — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 250283370.74
Net income (USD): -36896000
P/B ratio: 15.029326291959407
Pays dividend: no
Net asset value (USD): 16653000
Net cash (USD): 12930000
Net cash to market cap %: 5.166144263508412
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 9.258934192063752 (Safe Zone)
Piotroski F-score: 2 (Weak)
IMNM — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 1211779215.8
Net income (USD): -106806000
P/B ratio: 10.10809976310038
Pays dividend: no
Net asset value (USD): 119882000
Net cash (USD): 109484000
Net cash to market cap %: 9.03497919195785
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 23.71931684971896 (Safe Zone)
Piotroski F-score: 6 (Neutral)
IMNM — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 1202719184.28
Net income (USD): -292963000
Revenue growth %: -35.5043515480097
Smoothed growth %: -35.5043515480097
P/B ratio: 6.638805422018602
Pays dividend: no
Net asset value (USD): 181165000
Net cash (USD): 158227000
Net cash to market cap %: 13.155772525132004
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 7.973719341047484 (Safe Zone)
Piotroski F-score: 2 (Weak)
IMNM — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 2432618463.12
Net income (USD): -212394000
Revenue growth %: -23.227519079747815
Smoothed growth %: -23.227519079747815
P/B ratio: 3.834862941846919
Pays dividend: no
Net asset value (USD): 634343000
Net cash (USD): 604637000
Net cash to market cap %: 24.855397965882066
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 28.398762780011342 (Safe Zone)
Piotroski F-score: 5 (Neutral)
INAB — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 1262958485.3999999
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
INAB — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 664563576.6
Net income (USD): -28521000
P/B ratio: 29.234716549357735
Pays dividend: no
Net asset value (USD): 22732000
Net cash (USD): 7875000
Net cash to market cap %: 1.184988205385796
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 33.83970468690102 (Safe Zone)
Piotroski F-score: 2 (Weak)
INAB — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 397012006.8
Net income (USD): -30007000
P/B ratio: 15.92060018446485
Pays dividend: no
Net asset value (USD): 24937000
Net cash (USD): 12510000
Net cash to market cap %: 3.151038201799795
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 21.1139521840997 (Safe Zone)
Piotroski F-score: 4 (Weak)
INAB — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 73936294.02
Net income (USD): -30437000
P/B ratio: 5.106803012847078
Pays dividend: no
Net asset value (USD): 14478000
Net cash (USD): 4654000
Net cash to market cap %: 6.294608164619501
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -5.390995576579094 (Distress Zone)
Piotroski F-score: 2 (Weak)
INAB — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 22439809.08
Net income (USD): -19440000
P/B ratio: 0.8142756760287393
Pays dividend: no
Net asset value (USD): 27558000
Net cash (USD): 22368000
Net cash to market cap %: 99.67999246453483
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -4.380332155225325 (Distress Zone)
Piotroski F-score: 5 (Neutral)
INBS — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Medical Devices
Lynch category:  (confidence: Low)
Market cap (USD): 41378935.800000004
Pays dividend: no
Net cash (USD): 3989431
Net cash to market cap %: 9.64121218409875
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
INBS — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category:  (confidence: Low)
Market cap (USD): 33485844
Pays dividend: no
Net cash (USD): 2242209
Net cash to market cap %: 6.695990699831249
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
INBS — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Turnaround (confidence: High)
Market cap (USD): 34442582.4
Net income (USD): -2543526
P/B ratio: 6.966871490276846
Pays dividend: no
Net asset value (USD): 1309626
Net cash (USD): -1833649
Net cash to market cap %: -5.323784897151034
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -4.967217791627704 (Distress Zone)
Piotroski F-score: 1 (Weak)
INBS — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Turnaround (confidence: High)
Market cap (USD): 41139751.199999996
Net income (USD): -3090104
P/B ratio: 14.620584372014738
Pays dividend: no
Net asset value (USD): -794183
Net cash (USD): -4416053
Net cash to market cap %: -10.734272500899326
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -7.297820075767462 (Distress Zone)
Piotroski F-score: 4 (Weak)
INBS — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Turnaround (confidence: High)
Market cap (USD): 24396829.2
Net income (USD): -2983006
P/B ratio: 7.119152220544983
Pays dividend: no
Net asset value (USD): 147924
Net cash (USD): -4951275
Net cash to market cap %: -20.29474797487208
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -7.781505098587157 (Distress Zone)
Piotroski F-score: 6 (Neutral)
INBS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Turnaround (confidence: High)
Market cap (USD): 22794292.38
Net income (USD): -2677590
P/B ratio: 2.0931761239933366
Pays dividend: no
Net asset value (USD): 7823693
Net cash (USD): -6022860
Net cash to market cap %: -26.422667129094712
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -3.343778803429057 (Distress Zone)
Piotroski F-score: 6 (Neutral)
INBS — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Medical Devices
Lynch category: Turnaround (confidence: High)
Market cap (USD): 4185730
Net income (USD): -2862712
Revenue growth %: 45.541230430243104
Smoothed growth %: 45.541230430243104
P/B ratio: 0.915597619832263
Pays dividend: no
Net asset value (USD): 5962391
Net cash (USD): 750728
Net cash to market cap %: 17.935413894350567
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -6.449149339577189 (Distress Zone)
Piotroski F-score: 2 (Weak)
INCY — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Medium)
Market cap (USD): 13205600445.499998
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
INCY — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Medium)
Market cap (USD): 13798953445.849998
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
INCY — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 12096809485.25
Net income (USD): 158203000
P/E ratio: 19.11596095720372
P/B ratio: 3.2983235694247104
Pays dividend: no
Net asset value (USD): 3404359000
Net cash (USD): 326856000
Net cash to market cap %: 2.702001717052296
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 3.944247182215676 (Safe Zone)
Piotroski F-score: 4 (Weak)
INCY — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 13605164755.499998
Net income (USD): 404999000
P/E ratio: 24.1568118641269
P/B ratio: 3.261923078887233
Pays dividend: no
Net asset value (USD): 3888891000
Net cash (USD): 771287000
Net cash to market cap %: 5.669075045108888
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 5.695936228416593 (Safe Zone)
Piotroski F-score: 8 (Strong)
INCY — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 16943524565.550001
Net income (USD): 424169000
P/E ratio: 17.16024125232562
P/B ratio: 3.6428333381815508
Pays dividend: no
Net asset value (USD): 4376180000
Net cash (USD): 1250658000
Net cash to market cap %: 7.381333176350269
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 7.033139104293126 (Safe Zone)
Piotroski F-score: 7 (Neutral)
INCY — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 19732483449.35
Net income (USD): 299279000
P/E ratio: 15.336325690242102
P/B ratio: 3.8185907031147495
Pays dividend: no
Net asset value (USD): 4917347000
Net cash (USD): 1790109000
Net cash to market cap %: 9.071889022965163
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 7.659220567069711 (Safe Zone)
Piotroski F-score: 7 (Neutral)
INCY — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 23508367360
Net income (USD): 303330000
EPS growth %: 91.73467001257877
Revenue growth %: 20.8736268850354
Smoothed growth %: 91.73467001257877
P/E ratio: 13.293785310734464
P/B ratio: 3.344123791488547
PEG ratio: 0.14491560615971696
Pays dividend: no
Net asset value (USD): 5379683000
Net cash (USD): 2299559000
Net cash to market cap %: 9.781874533374655
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 9.289397944481314 (Safe Zone)
Piotroski F-score: 6 (Neutral)
INDBANK.NS — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category:  (confidence: Low)
Market cap (USD): 12641027.561651062
Pays dividend: no
Net cash (USD): 812180.1397863643
Net cash to market cap %: 6.424953476490042
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
INDBANK.NS — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 11405359.561510354
Net income (USD): 426577.34470158344
P/E ratio: 26.736908800182743
P/B ratio: 1.2567948363474326
Pays dividend: no
Net asset value (USD): 9065542.021924483
Net cash (USD): 1278696.7113276492
Net cash to market cap %: 11.211366940529123
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.516808858078946 (Safe Zone)
Piotroski F-score: 2 (Weak)
INDBANK.NS — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 22971681.022072934
Net income (USD): 1079110.2050605589
EPS growth %: 152.969413041722
Revenue growth %: 21.108661519543087
Smoothed growth %: 152.969413041722
P/E ratio: 21.28761354896443
P/B ratio: 2.2977439847985184
PEG ratio: 0.1391625497259265
Pays dividend: no
Net asset value (USD): 9991509.773354119
Net cash (USD): 4798213.215013791
Net cash to market cap %: 20.887514546294213
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 6.566403607063281 (Safe Zone)
Piotroski F-score: 7 (Neutral)
INDBANK.NS — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 14563134.368070954
Net income (USD): 989396.7734393266
EPS growth %: -8.313648708029561
Revenue growth %: 0.17756181307402685
EPS 2-year CAGR %: 52.295247694295746
Smoothed growth %: 52.295247694295746
P/E ratio: 14.719205438124485
P/B ratio: 1.3592006627752562
PEG ratio: 0.28146353802871504
Pays dividend: no
Net asset value (USD): 10703542.202478372
Net cash (USD): 6479962.590600887
Net cash to market cap %: 44.49565887964288
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.1938767368096395 (Safe Zone)
Piotroski F-score: 3 (Weak)
INDBANK.NS — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Financial Services | Industry: Capital Markets
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 15411971.852479864
Net income (USD): 755065.7058075456
EPS growth %: -23.68423608429637
Revenue growth %: -17.99171104698146
EPS 2-year CAGR %: -16.351246635169247
Smoothed growth %: -23.68423608429637
P/E ratio: 0.19505530462283074
P/B ratio: 1.306999394857759
Pays dividend: no
Net asset value (USD): 10454281.475201357
Net cash (USD): 6604239.0843577795
Net cash to market cap %: 42.8513570331698
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.816708297271358 (Safe Zone)
Piotroski F-score: 5 (Neutral)
INDI — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Technology | Industry: Semiconductors
Lynch category:  (confidence: Low)
Market cap (USD): 843041478.09
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
INDI — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Technology | Industry: Semiconductors
Lynch category:  (confidence: Low)
Market cap (USD): 855718793.55
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
INDI — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Technology | Industry: Semiconductors
Lynch category: Turnaround (confidence: High)
Market cap (USD): 431028725.64
Net income (USD): -34546000
P/B ratio: 0.9983687270604749
Pays dividend: no
Net asset value (USD): -65160000
Net cash (USD): -240681000
Net cash to market cap %: -55.83873781095032
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 0.05471223453091134 (Distress Zone)
Piotroski F-score: 2 (Weak)
INDI — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Technology | Industry: Semiconductors
Lynch category: Turnaround (confidence: High)
Market cap (USD): 752187383.96
Net income (USD): -39038000
P/B ratio: 1.8120805403087479
Pays dividend: no
Net asset value (USD): -84373000
Net cash (USD): -259974000
Net cash to market cap %: -34.562398352300065
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 0.35747233363872 (Distress Zone)
Piotroski F-score: 4 (Weak)
INDI — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Technology | Industry: Semiconductors
Lynch category: Turnaround (confidence: High)
Market cap (USD): 859944565.37
Net income (USD): -38289000
P/B ratio: 2.1886330478679814
Pays dividend: no
Net asset value (USD): -125536000
Net cash (USD): -301278000
Net cash to market cap %: -35.03458387115593
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 0.3490404719873358 (Distress Zone)
Piotroski F-score: 4 (Weak)
INDI — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Technology | Industry: Semiconductors
Lynch category: Turnaround (confidence: High)
Market cap (USD): 745848726.2299999
Net income (USD): -31193000
P/B ratio: 1.9422486380148587
Pays dividend: no
Net asset value (USD): -130521000
Net cash (USD): -311317000
Net cash to market cap %: -41.739965364504506
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 0.15682291241591534 (Distress Zone)
Piotroski F-score: 4 (Weak)
INDI — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Technology | Industry: Semiconductors
Lynch category: Turnaround (confidence: High)
Market cap (USD): 733171392
Net income (USD): -43192000
Revenue growth %: 2.551916711356029
Smoothed growth %: 2.551916711356029
P/B ratio: 1.949704149648947
Pays dividend: no
Net asset value (USD): -151389000
Net cash (USD): -346180000
Net cash to market cap %: -47.21679047728038
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 0.007526459590243964 (Distress Zone)
Piotroski F-score: 4 (Weak)
INDP — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Medium)
Market cap (USD): 21265474910.399998
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
INDP — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 5409638354.400001
Net income (USD): -14322798
P/B ratio: 219.63200266012032
Pays dividend: no
Net asset value (USD): 24630465
Net cash (USD): 22999468
Net cash to market cap %: 0.4251572192675889
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 943.1400932198674 (Safe Zone)
Piotroski F-score: 2 (Weak)
INDP — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 6566181726.72
Net income (USD): -15423471
P/B ratio: 543.7157135056868
Pays dividend: no
Net asset value (USD): 12076498
Net cash (USD): 10514673
Net cash to market cap %: 0.16013374953075488
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 1376.646086286036 (Safe Zone)
Piotroski F-score: 2 (Weak)
INDP — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 3141853999.9199996
Net income (USD): -15022027
P/B ratio: 796.4394308869101
Pays dividend: no
Net asset value (USD): 3944875
Net cash (USD): 2392872
Net cash to market cap %: 0.07616114561850834
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 537.5323650350405 (Safe Zone)
Piotroski F-score: 3 (Weak)
INDP — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 387735162.84000003
Net income (USD): -20848916
P/B ratio: 123.02831071144023
Pays dividend: no
Net asset value (USD): 3151593
Net cash (USD): 2349053
Net cash to market cap %: 0.6058395588355093
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 18.927797844569934 (Safe Zone)
Piotroski F-score: 3 (Weak)
INDRAMEDCO.NS — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category:  (confidence: Low)
Market cap (USD): 463675726.8275203
P/B ratio: 7.4021188433156
Pays dividend: no
Net asset value (USD): 62541806.02006689
Net cash (USD): 4242713.8079312
Net cash to market cap %: 0.9150174491470455
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
INDRAMEDCO.NS — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 553532238.3727707
Net income (USD): 3824455.0646928544
P/E ratio: 36.18373265010668
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
INDRAMEDCO.NS — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 409196006.18508583
Net income (USD): 4794248.304886603
P/E ratio: 21.337860502970155
P/B ratio: 5.866230872338982
Pays dividend: no
Net asset value (USD): 69685527.23871872
Net cash (USD): 8530512.041150335
Net cash to market cap %: 2.084700708758103
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 9.962059558900437 (Safe Zone)
Piotroski F-score: 3 (Weak)
INDRAMEDCO.NS — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 515765213.3161714
Net income (USD): 6021530.540603791
P/E ratio: 35.229301422392076
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
INDRAMEDCO.NS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 457599101.03598094
Net income (USD): 4567227.358805837
P/E ratio: 23.824028310018555
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
INDRAMEDCO.NS — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Medical Care Facilities
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 354217639.33870286
Net income (USD): 4419245.442984316
EPS growth %: 15.552290933747168
Revenue growth %: 2.076473914158481
Smoothed growth %: 15.552290933747168
P/E ratio: 0.19623233908948196
P/B ratio: 4.590026756891826
PEG ratio: 0.012617584118341962
Dividend yield: 0.01
Pays dividend: yes
Net asset value (USD): 78426239.93217465
Net cash (USD): 2461848.2407799885
Net cash to market cap %: 0.6950100636930646
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 8.820809713367845 (Safe Zone)
Piotroski F-score: 2 (Weak)
INDUSTOWER.NS — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Communication Services | Industry: Telecom Services
Lynch category:  (confidence: Medium)
Market cap (USD): 7300873738.015561
Pays dividend: no
Net cash (USD): 79177106.68600819
Net cash to market cap %: 1.0844880972770965
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
INDUSTOWER.NS — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Communication Services | Industry: Telecom Services
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 4593400024.019488
Net income (USD): 248477466.5042631
P/E ratio: 18.48618343
P/B ratio: 1.7864854305975981
Pays dividend: no
Net asset value (USD): 2568380024.360536
Net cash (USD): -3065152253.349574
Net cash to market cap %: -66.72948659645344
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.1560260286173274 (Grey Zone)
Piotroski F-score: 4 (Weak)
INDUSTOWER.NS — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Communication Services | Industry: Telecom Services
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 9210866260.011995
Net income (USD): 723851780.7890635
EPS growth %: 191.31485883716718
Revenue growth %: -0.7879571811046789
Smoothed growth %: 191.31485883716718
P/E ratio: 12.72479602104636
P/B ratio: 2.840710894797107
PEG ratio: 0.06651232475297045
Pays dividend: no
Net asset value (USD): 3240868209.6174603
Net cash (USD): -3449538313.946516
Net cash to market cap %: -37.450748024887986
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 3.0533151043917206 (Safe Zone)
Piotroski F-score: 6 (Neutral)
INDUSTOWER.NS — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Communication Services | Industry: Telecom Services
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 10288394812.430857
Net income (USD): 1161059153.612345
EPS growth %: 60.40012395171374
Revenue growth %: 2.6750497888954823
EPS 2-year CAGR %: 116.16414935520089
Smoothed growth %: 116.16414935520089
P/E ratio: 8.861215021147794
P/B ratio: 2.7080471663297327
PEG ratio: 0.07628183970987827
Pays dividend: no
Net asset value (USD): 3794750993.687164
Net cash (USD): -3219090483.984101
Net cash to market cap %: -31.288559028612166
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 3.613211774633732 (Safe Zone)
Piotroski F-score: 8 (Strong)
INDUSTOWER.NS — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Communication Services | Industry: Telecom Services
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 11028350296.227215
Net income (USD): 757195845.6973294
EPS growth %: -34.784042368426796
Revenue growth %: -2.2139006745839
EPS 2-year CAGR %: 2.2773077849336687
Smoothed growth %: 2.2773077849336687
P/E ratio: 0.16291712472294545
P/B ratio: 2.769170663562593
PEG ratio: 0.07153935265175003
Pays dividend: no
Net asset value (USD): 4196407376.0067825
Net cash (USD): -2303094531.5811787
Net cash to market cap %: -20.88340023411357
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 3.038100436408584 (Safe Zone)
Piotroski F-score: 7 (Neutral)
INFOMEDIA.NS — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Financial Services | Industry: Shell Companies
Lynch category:  (confidence: Low)
Market cap (USD): 3673712.9711196097
Pays dividend: no
Net cash (USD): 2901.2264275352763
Net cash to market cap %: 0.07897259394903385
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
INFOMEDIA.NS — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Financial Services | Industry: Shell Companies
Lynch category: Turnaround (confidence: High)
Market cap (USD): 2598358.4774665046
Net income (USD): -421144.94518879417
Pays dividend: no
Net asset value (USD): -6164543.239951279
Net cash (USD): -7313934.226552985
Net cash to market cap %: -281.48287813174807
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -14.92783551793289 (Distress Zone)
Piotroski F-score: 2 (Weak)